Author: Mackenzie Bean

Baptist Health Lexington in Kentucky will open a new cancer center June 13, integrated within the hospital's $253 million outpatient medical center.

Blood Centers of America will partner with Galapagos to help manufacture the Belgian biotech firm's CAR-T cell therapies, the companies said May 15.

Researchers at the Sylvester Comprehensive Cancer Center at the University of Miami have developed a nanoparticle that can cross the blood-brain barrier, potentially opening the door for new treatments for brain metastases.

Los Angeles-based Keck Medicine of USC will assess the feasibility of providing home-based immunotherapy to patients with non-small cell lung cancer via a new clinical trial.

The University of Arkansas for Medical Sciences Winthrop P. Rockefeller Cancer Institute has named Yong Zhu, PhD, associate director for population science and translational science, the Little Rock-based organization said April 2.

Though COVID-19 deaths among the general population were lower during the winter omicron surge compared to the preceding winter, the death rate for cancer patients was higher, according to a study published Aug. 31 in JAMA Oncology.

CMS has agreed to provide Medicare coverage for the first whole-genome sequencing test for cancer.

Duarte, Calif.-based City of Hope has named David Craig, PhD, professor and founding chair of the newly created department of integrative translational sciences within the Beckman Research Institute of City of Hope.

The FDA is warning healthcare providers about a rare, potential risk for certain cancers in the scar tissue that grows around breast implants, according to a Sept. 8 safety alert.

The University of Texas MD Anderson Cancer Center in Houston earned the No. 1 spot on U.S. News & World Report's 2022-23 Best Hospitals for Cancer ranking released July 26.